Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

[1]  D. Pham‐Dinh,et al.  Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Hartung,et al.  Acute Disseminated Encephalomyelitis An Update , 2005 .

[3]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[4]  G. Giovannoni,et al.  Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis , 2005, Multiple sclerosis.

[5]  D. Hafler,et al.  Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein1 , 2005, The Journal of Immunology.

[6]  S. Yum,et al.  Acute Disseminated Encephalomyelitis in Children: Discordant Neurologic and Neuroimaging Abnormalities and Response to Plasmapheresis , 2005, Pediatrics.

[7]  M. Rewers,et al.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.

[8]  C. Breithaupt,et al.  Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)‐specific autoantibody repertoire , 2004, European journal of immunology.

[9]  S. Hauser,et al.  Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination , 2004, European journal of immunology.

[10]  E. Bonifacio,et al.  Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects , 2004, Neurology.

[11]  Rajesh Ramachandran Nair.  Acute disseminated encephalomyelitis: clinical features and HLA‐DR linkage , 2004, European journal of neurology.

[12]  I. N. Martinenko,et al.  Acute disseminated encephalomyelitis in children: clinical features and HLA‐DR linkage , 2003, European journal of neurology.

[13]  H. Ulmer,et al.  Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. , 2003, The New England journal of medicine.

[14]  D. Wingerchuk.  Postinfectious encephalomyelitis , 2003, Current neurology and neuroscience reports.

[15]  Martin Wiedmann,et al.  The Organizing Principle in the Formation of the T Cell Receptor-CD3 Complex , 2002, Cell.

[16]  W. Hagopian,et al.  Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. , 2002, Diabetes care.

[17]  H. Arakawa,et al.  Plasmapheresis in fulminant acute disseminated encephalomyelitis , 2001, Brain and Development.

[18]  T. Honjo,et al.  High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia , 1999, The Journal of experimental medicine.

[19]  W. Poewe,et al.  Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. , 1999, Brain : a journal of neurology.

[20]  U. Brehm,et al.  Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG) , 1999, Journal of Neuroimmunology.

[21]  D. Hafler,et al.  Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis , 1998, Journal of Neuroimmunology.

[22]  J. Fjell,et al.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.

[23]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[24]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[25]  T. Tabira,et al.  Semple rabies vaccine: presence of myelin basic protein and proteolipid protein and its activity in experimental allergic encephalomyelitis , 1989, Journal of the Neurological Sciences.

[26]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[27]  H. Weiner,et al.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.

[28]  A. Moser,et al.  Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. , 1987, The New England journal of medicine.

[29]  J. Wolinsky,et al.  Measles encephalomyelitis--clinical and immunologic studies. , 1984, The New England journal of medicine.

[30]  K. Johnson.  An Update. , 1984, Journal of food protection.

[31]  W. Mcdonald,et al.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. , 1979, British medical journal.

[32]  B. Zweiman,et al.  Cell‐mediated immunity to myelin basic protein in acute disseminated encephalomyelitis , 1974, Neurology.